Showing results (371-380 of 2,117) with videos related to
Sort By:
Pageof 212
International Clinical Psychopharmacology|November 1, 2013
Factors associated with antidepressant, anxiolytic, and other psychotropic medication use to treat psychiatric symptoms in the city of São Paulo, BrazilSergio L Blay, Gerda G Fillenbaum, José C Pitta, et al.International Clinical Psychopharmacology|August 22, 2013
Asenapine in the treatment of borderline personality disorder: an atypical antipsychotic alternativeAna Martín-Blanco, Barbara Patrizi, Laia Villalta, et al.International Clinical Psychopharmacology|August 24, 2013
The advantage of using 3-week data to predict response to aripiprazole at week 6 in first-episode psychosisJong-Il Park, Dong-Hwan Cho, Sang Woo Hahn, et al.International Clinical Psychopharmacology|July 1, 1989
A double-blind comparative study of fluoxetine and dothiepin in the treatment of depression in general practiceS J Corne, J R HallInternational Clinical Psychopharmacology|January 9, 2016
Genetic variation in the tryptophan hydroxylase 2 gene moderates depressive symptom trajectories and remission over 8 weeks of escitalopram treatmentYun-Ai Su, Ji-Tao Li, Wen-Ji Dai, et al.International Clinical Psychopharmacology|January 1, 1989
A multicentre open trial of fluoxetine in depressed out-patients in BelgiumR BrasseurInternational Clinical Psychopharmacology|October 15, 2015
Therapeutic effects of minocycline on mild-to-moderate depression in HIV patients: a double-blind, placebo-controlled, randomized trialHamid Emadi-Kouchak, Payam Mohammadinejad, Ali Asadollahi-Amin, et al.International Clinical Psychopharmacology|February 3, 2016
Effects of antipsychotics on insight in schizophrenia: results from independent samples of first-episode and acutely relapsed patientsBłażej Misiak, Dorota Frydecka, Jan A Beszłej, et al.International Clinical Psychopharmacology|January 1, 1989
Pyritinol treatment of SDAT patients: evaluation by psychiatric and neurological examination, psychometric testing and rCBF measurementsS Knezevic, Z Mubrin, J Risberg, et al.International Clinical Psychopharmacology|October 1, 1989
Anticholinergic drugs in psychiatryP MallettPageof 212